# DESCRIPTION

## FIELD OF THE INVENTION

- relate to preventing airway remodeling and/or pulmonary inflammation

## BACKGROUND

- introduce asthma statistics
- discuss airway remodeling in asthma
- describe adenosine's role in asthma and COPD
- summarize clinical evidence for adenosine's involvement
- highlight need for new methods of treating asthma

## SUMMARY OF THE INVENTION

- introduce method for treating airway remodeling and/or pulmonary inflammation
- describe administration of A2B receptor antagonist
- outline structure of Formula I and Formula II
- define R¹, R², R³, X, Y, and Z
- describe preferred compounds
- outline pharmaceutical formulations
- describe oral administration
- list specific compounds

## DETAILED DESCRIPTION OF THE INVENTION

### Definitions and General Parameters

- define alkyl
- define substituted alkyl
- define lower alkyl
- define substituted lower alkyl
- define alkylene
- define lower alkylene
- define substituted alkylene
- define aralkyl
- define alkoxy
- define alkylthio
- define alkenyl
- define lower alkenyl
- define substituted alkenyl
- define alkynyl
- define various other terms
- define heteroaryl
- define heteroarylene
- define heteroaralkyl
- define heteroaryloxy
- define heterocyclyl
- define thiol
- define substituted alkylthio
- define heteroarylthio
- define sulfoxide
- define sulfone
- define keto
- define thiocarbonyl
- define carboxy

### Nomenclature

- illustrate naming and numbering of compounds of Formula I

### The Method of the Invention

- describe method of preventing airway remodeling and/or pulmonary inflammation

### Pharmaceutical Compositions

- describe pharmaceutical compositions containing compounds of Formula I

### The A2B Adenosine Receptor Antagonists

- describe A2B adenosine receptor antagonists
- describe methods for determining binding affinity of compounds for A2B receptor

### Synthetic Reaction Parameters

- define solvents and inert organic solvents
- describe synthesis of compounds of Formula I and II
- describe Step 1 of synthesis: reduction of compound of formula (1)
- describe Step 2 of synthesis: reaction of compound of formula (2) with carboxylic acid
- describe alternative preparation of compound of formula (3)
- describe Step 3 of synthesis: cyclization reaction
- describe preparation of compound of formula (1)
- describe Step 1 of alternative synthesis: reaction of compound of formula (4) with ethyl cyanoacetate
- describe Step 2 and 3 of alternative synthesis: reaction of compound of formula (5) with dimethylacetal of N,N-dimethyl
- describe Step 4 of alternative synthesis: reaction of compound of formula (7) with aqueous ammonia
- describe Step 5 of alternative synthesis: reaction of compound of formula (8) with sodium nitrite
- describe alternative preparation of compound of formula (8)
- describe Step 2 and 3 of alternative synthesis: reaction of compound of formula (10) with dimethylacetal of N,N-dimethyl
- describe Step 4 of alternative synthesis: reaction of compound of formula (7) with aqueous ammonia
- describe Step 5 of alternative synthesis: reaction of compound of formula (8) with sodium nitrite
- describe alternative synthesis of compound of formula (3)

### Utility Testing and Administration

- describe general utility
- outline testing methods
- discuss administration routes
- list pharmaceutical composition components
- describe controlled release systems
- outline transdermal delivery devices
- specify dosage ranges

### Example 1

- prepare compound of Formula (5)

### Example 2

- prepare compound of formula (6) in which R2 is Ethyl
- prepare compound of formula (6) in which R2 is Methyl
- prepare compound of formula (6) varying R2
- prepare compound of formula (7) in which R1 is n-Propyl and R2 is Ethyl
- prepare compound of formula (7) varying R1 and R2
- prepare compound of formula (8) in which R1 is n-Propyl and R2 is Ethyl
- prepare compound of formula (8) varying R1 and R2
- prepare compound of formula (1) in which R1 is n-Propyl and R2 is Ethyl
- prepare compound of formula (1) varying R1 and R2
- prepare compound of formula (2) in which R1 is n-Propyl and R2 is Ethyl
- prepare compound of formula (2) varying R1 and R2
- prepare compounds of formula (3)
- prepare compounds of formula I
- prepare compounds of formula (10)
- prepare compounds of formula (11)
- vary R1, R2, X, Y, and Z
- prepare compounds of formula (11)
- prepare compounds of formula (12)
- prepare compounds of formula (13)
- prepare compounds of formula (13), varying R1, X, Y, and Z
- prepare compounds of formula (3)
- prepare compounds of formula (3), varying R1, X, Y, and Z
- prepare compounds of formula (3), varying R2
- prepare compounds of formula (3), varying R1 and R2
- prepare compounds of formula (3), varying R1, R2, X, Y, and Z
- prepare compound of formula I
- prepare compound of formula I, varying R1, R2, X, Y, and Z
- prepare compound of formula (14)
- prepare compound of formula (15)
- prepare compound of formula (16)
- prepare compound of formula (3)
- prepare compound of formula (3), varying R1, R2, X, Y, and Z
- synthesize compound
- characterize compound
- describe radioligand binding for A2B adenosine receptor
- describe radioligand binding for other adenosine receptors
- measure cAMP levels
- describe effect of A2B antagonist on airway restructuring
- describe mouse model
- describe cellular differentials and histology
- analyze mRNA levels
- quantify collagen levels
- perform immunohistochemistry
- determine alveolar airspace size
- present histological analysis results
- present bronchiolalveolar lavage analysis results
- examine effect on inflammatory markers
- examine effect on myofibroblast accumulation
- examine effect on collagen deposition
- examine effect on profibrotic mediators
- examine effect on protease/anti-protease levels and alveolar destruction

